For an occasional cannabis user, blood THC usually drops below 5 nanograms per milliliter (ng/mL) within a few hours of smoking. For someone who uses cannabis daily or near-daily, the timeline stretches dramatically: some heavy users still measure above 5 ng/mL a full day or more after their last use, and detectable THC can linger in blood for weeks. The 5 ng/mL figure matters because several U.S. states treat it as a legal line for impaired driving, but the biology behind THC clearance makes the answer far more individual than a single number suggests.
Why Frequency of Use Changes Everything
THC is fat-soluble. When you inhale or ingest cannabis, THC floods into your bloodstream quickly, but it also moves into fatty tissue throughout your body. In an occasional user, there is not much THC stored in fat, so the drug clears from blood relatively fast after the initial spike. In a frequent user, fat tissue acts like a reservoir that has been filling up over weeks or months. Even after you stop using, THC slowly leaks back into the bloodstream from those stores, keeping blood levels elevated far longer than you might expect.
THC has what pharmacologists describe as a long terminal half-life of roughly 21.5 hours, which reflects that slow release from deep tissue compartments back into blood.1PubMed. Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics The initial drop in blood THC after a single use is much faster than this, because most of the THC is being redistributed into tissues and metabolized in the liver. But the tail end of elimination, where you are waiting for those last nanograms to clear, is governed by that slow release from fat. This is why a daily user and a once-a-month user live in completely different clearance worlds.
Clearance Timelines for Occasional Users
If you smoke cannabis once or only a few times per month, your blood THC will typically spike to its highest level within minutes of inhaling and then plummet over the next few hours. Most occasional users will be well below 5 ng/mL within three to six hours after a single smoking session, and many will be below 2 ng/mL by that point. The rapid early decline happens because THC is being distributed into tissues and broken down in the liver, where it converts primarily into 11-OH-THC (an active metabolite) and then into THC-COOH (an inactive metabolite that shows up on urine tests).2PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis
That said, “occasional” is doing a lot of work here. Someone who smokes a small amount once per week and someone who smokes a large joint every three or four days are both loosely called occasional users, but the person with more frequent exposure will have more THC stored in fat and a longer tail of detectable blood levels. Even among non-daily users, predictions based on pharmacokinetic modeling show that THC can be present in blood between smoking sessions, depending on the dose and the interval between uses.3PubMed. Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users
Clearance Timelines for Daily and Heavy Users
This is where the timeline gets surprisingly long. In a study of chronic, frequent cannabis smokers admitted to a monitored research unit, the median blood THC concentration at admission was 4.2 ng/mL. Levels dropped significantly in the first 24 hours, but 16 out of 28 participants still had blood THC at or above 2 ng/mL two full days after admission. More strikingly, THC was still detectable in three of five participants tested at 30 days of sustained, verified abstinence, with a median concentration of 0.3 ng/mL at that point.4PubMed Central. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance A separate study of daily smokers found that only 1 out of 11 participants was THC-negative at 26 days, and about 5% still had THC at or above 1.0 ng/mL after 12 days of monitored abstinence.5PubMed Central. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws
A systematic review pulling together multiple studies found that some frequent users still had blood THC above 5 ng/mL (or the plasma equivalent above 7.5 ng/mL) after a full day of abstinence, and some had levels above 2 ng/mL after six days without cannabis.6PubMed Central. Per Se Driving Under the Influence of Cannabis Statutes and Blood Delta-9-Tetrahydrocannabinol Concentrations following Short-Term Cannabis Abstinence So if you are a heavy daily user and your concern is getting below 5 ng/mL in blood, a reasonable estimate is at least one to three days of abstinence, but individual variation is wide. Getting below 2 ng/mL could take a week or more, and trace amounts may persist for weeks.
Blood Versus Plasma Matters More Than You Think
When people talk about “5 nanograms,” the sample type makes a significant difference. THC concentrations in plasma are roughly two to three times higher than in whole blood drawn at the same moment. One study found the median whole-blood-to-plasma ratio for THC was about 0.39, meaning whole blood contains only about 40% of the THC concentration found in plasma from the same person at the same time.7PubMed Central. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing Another study estimated a multiplying factor of about 1.6 to convert from whole-blood THC levels to approximate plasma levels.8PubMed. Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people
This matters because per se driving laws in different states do not always specify which matrix they mean, and labs may report results in either whole blood or plasma. If the legal threshold is 5 ng/mL in whole blood, someone with 4 ng/mL in whole blood could easily have 7 or 8 ng/mL in plasma. If the lab reports plasma values and the statute references whole blood (or vice versa), the comparison becomes unreliable. When you read about timelines for getting “under 5 nanograms,” pay attention to whether the studies used whole blood or plasma, because the numbers are not interchangeable.
Can Exercise or Fasting Release Stored THC?
Because THC accumulates in fat, anything that breaks down fat cells (lipolysis) can theoretically push stored THC back into the bloodstream. Animal research demonstrated this directly: food deprivation and stress hormones both enhanced the release of fat-stored THC into blood in rats that had been chronically exposed to the drug.9PubMed Central. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure A human study found that moderate exercise on a stationary bike caused small but measurable increases in plasma THC in regular cannabis users.10PubMed. Exercise increases plasma THC concentrations in regular cannabis users
Before you panic about a jog before a blood test, the practical size of this effect appears to be modest. A controlled human study measuring serum THC during exercise and short-term fasting found average increases of about 25% in THC levels after exercise and somewhat smaller increases after fasting. Participants in that study had serum THC in the 0 to 3.6 ng/mL range at admission, and none exceeded 3.6 ng/mL at any point during the experiment, including during exercise and fasting challenges. The researchers concluded that moderate exercise like jogging and short-term fasting such as skipping meals for a day are unlikely to cause meaningful problems for most practical purposes.11PubMed Central. Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids? In one individual, however, the increase was close to a doubling, which shows the effect is not zero and can vary from person to person.
The bottom line on exercise is nuanced. Over days and weeks, burning fat should help clear THC faster by mobilizing it from storage. But in the hours immediately before a blood test, intense exercise could temporarily bump your levels up slightly. For most people, the bump is small and probably does not push someone from safe to over-the-limit, but for someone hovering right around 5 ng/mL, it is at least theoretically possible.
Oral Fluid Tests Have Their Own Window
Many roadside screening programs and workplace tests use oral fluid (saliva) rather than blood. THC in oral fluid behaves differently than in blood because much of what shows up in saliva right after smoking is residual THC deposited directly in the mouth, not THC that has been absorbed and circulated through the bloodstream. After vaporized cannabis, oral fluid THC peaks around 10 minutes and then declines rapidly.12PubMed Central. Detection of Δ(9) THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices
Despite that rapid decline, oral fluid can remain THC-positive for a surprisingly long time, especially in frequent smokers. In one controlled study, all 24 participants still had detectable oral fluid THC 13.5 hours after smoking. Using the commonly proposed confirmation cutoff of 2 ng/mL, all participants were positive for at least 6 hours. By 21 hours, about 71% of frequent smokers and only 10% of occasional smokers were still positive at that cutoff.13PubMed Central. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers Point-of-collection screening devices showed a similar pattern, with median last-positive times of about 12 hours for occasional smokers and 21 hours for frequent smokers.14PubMed Central. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices
Oral fluid testing is not governed by the same 5 ng/mL threshold used in blood-based per se laws. Different jurisdictions and testing programs set their own cutoffs, and these vary widely. But if your concern is specifically about a blood draw and the 5 ng/mL standard, oral fluid results from a roadside screen are typically a preliminary step, not the final legal measurement.
Urine Tests Measure Something Different Entirely
Standard urine drug screens detect THC-COOH, the inactive metabolite, not THC itself. This means a positive urine test does not tell anyone what your blood THC level is right now. It tells them you used cannabis at some point in the recent past. The detection window in urine depends heavily on your usage history. For people with low initial metabolite concentrations, the mean time to a first negative urine was less than a day, and the last positive came at an average of about four days. For those with high initial concentrations (heavy users), the mean last positive was around 15 days.15PubMed Central. Urinary Elimination of 11-Nor-9-carboxy-delta9-tetrahydrocannabinol in Cannabis Users During Continuously Monitored Abstinence
Young heavy users can take even longer. In a study of adolescent and young adult cannabis users with verified abstinence, 40% still had detectable urinary THC-COOH above 5 ng/mL after 25 or more days of abstinence, and about 19% were still formally “positive” under federal drug testing guidelines at that same time point.16PubMed Central. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence None of this tells you anything about blood THC at that moment. A person can be positive on a urine test and far below 5 ng/mL in blood, or theoretically negative on a urine screen while still having detectably elevated blood THC. The two measurements answer different questions.
Does How You Consume Cannabis Affect How Fast You Clear?
Inhaled cannabis (smoking and vaping) produces a sharp spike in blood THC that drops quickly in the first hour or two. Edibles produce a lower peak but maintain elevated blood levels for much longer because THC is absorbed gradually through the gut. A systematic review of different methods of cannabis use confirmed that inhaled routes result in higher peak THC levels, while edible cannabis has a longer duration of action.17PubMed. Effects of different methods of cannabis use on cognition and blood THC: A systematic review If you ate a high-dose edible, you might see elevated blood THC for considerably longer than someone who smoked the same total amount of THC, even though the smoker’s peak was higher.
The dose also matters in a straightforward way. Pharmacometric modeling using simulated THC plasma concentrations across doses from 2.5 mg to 100 mg showed that how quickly you cross back below a given threshold is heavily dose-dependent, with higher doses keeping levels elevated for correspondingly longer periods.18PubMed Central. Evaluation of Cannabis Per Se Laws: A Semi-Mechanistic Pharmacometrics Model for Quantitative Characterization of THC and Metabolites in Oral Users This is intuitive, but worth stating explicitly: if you consumed a very high-potency product, your clearance clock starts from a higher point and takes longer to tick down to 5 ng/mL than if you took a modest dose.
The Weak Link Between 5 Nanograms and Actual Impairment
The 5 ng/mL threshold exists in law, but the scientific support for it as a reliable indicator of impairment is shakier than you might expect. One well-known study found that impairment in driving-related tasks started becoming apparent at serum THC concentrations between 2 and 5 ng/mL, and that at concentrations between 5 and 10 ng/mL, roughly 75 to 90% of observations showed significant impairment.19PubMed. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment On the surface, that seems to support the 5 ng/mL cutoff. But the relationship between THC blood concentration and impairment is much weaker than the equivalent relationship for alcohol.
A large study comparing how well blood drug concentrations predicted clinical impairment found that for alcohol, the correlation was strong, and the percentage of clinically impaired cases rose from 60% at lower concentrations to 97% at higher ones. For THC, the increase was only from 41% to 55% across concentration windows, and the overall correlation between THC concentration and impairment degree was very low.20PubMed. The relationship between clinical impairment and blood drug concentration: Comparison between the most prevalent traffic relevant drug groups The reason is partly what we have already covered: a chronic daily user may have a blood THC of 4 ng/mL simply from residual stores, with no recent consumption and no active impairment. Research directly tested this: regular cannabis users who exceeded per se cutpoints during short-term abstinence showed no difference in simulated driving performance compared with those below the cutpoints.6PubMed Central. Per Se Driving Under the Influence of Cannabis Statutes and Blood Delta-9-Tetrahydrocannabinol Concentrations following Short-Term Cannabis Abstinence
This disconnect does not mean cannabis does not impair driving. It does, particularly in the first couple of hours after use when blood levels are high and actively falling. The problem is that a single blood THC number is a poor proxy for whether someone is actually impaired at the moment of the draw, because tolerance, time since last use, and accumulated tissue stores all muddy the picture.
Genetic Variation and Individual Differences
THC is metabolized primarily by liver enzymes in the CYP family, particularly CYP2C9. Genetic variants that slow these enzymes down could theoretically mean slower clearance for some people. A study of 27 individuals after controlled cannabis vaporization found that about 44% carried function-impairing CYP2C9 gene variants. However, no statistically significant differences in blood THC or metabolite concentrations were observed across the different genetic profiles, though slight trends in the expected direction were visible.21PubMed Central. Assessing the influence of CYP2C9 and CYP2C19 genotypes on the metabolism of CBD-cannabis after controlled single and repetitive consumption The study was small, and the cannabis used was a high-CBD, low-THC formulation, so definitive conclusions about how much genetics shift clearance timelines in real-world heavy users are still lacking. But the evidence so far suggests that while genetics play a role in THC metabolism, the overwhelming driver of how long it takes to clear 5 ng/mL is how much and how often you use, not your DNA.
Lab and Sample Handling Can Shift Your Numbers
It is worth knowing that the measured THC concentration in your blood sample is not just a function of your biology. How the sample is collected and stored also matters. THC and related cannabinoids adsorb onto certain types of collection tubes, particularly gel separation tubes commonly used in clinical settings. Over a three-month storage period, THC concentrations in plasma stored in gel separator tubes dropped by more than 80%, while tubes without gel separators showed much smaller declines.22PubMed. Adsorption of Tetrahydrocannabinol, Metabolites, and Related Cannabinoids During Storage of Plasma Samples in Gel Separation Tubes For someone right around the 5 ng/mL threshold, the type of tube used and the delay before analysis could conceivably change whether the result comes back above or below the legal limit. Multi-laboratory validation studies have confirmed that well-calibrated instruments produce equivalent results at the low concentrations relevant to per se limits, but the pre-analytical handling of the sample introduces its own variability.23Forensic Science & Criminology. Multi-laboratory validation of a Δ9-tetrahydrocannabinol LC-MS/MS test kit designed for quantifying THC and marijuana metabolites in blood
None of this is something you can control as a test subject, but it is a genuine source of uncertainty in forensic results, and it is one reason defense attorneys in DUI-cannabis cases sometimes challenge blood draw procedures and chain-of-custody protocols.